Morning Breakouts

Latest KFF Health News Stories

Longer Looks: Interesting Reads You Might Have Missed

Morning Briefing

Each week, KHN finds longer stories for you to enjoy. This week’s selections include stories on mental health, Alzheimer’s, smartphone accessibility updates, menstrual leave, covid, hockey great Vladimir Konstantinov, and more.

Peanut Butter Recall Hits Other Makers’ Products Across States, Borders

Morning Briefing

The footprint of the Jif peanut butter recall, according to a report at NPR, is extending into other companies’ products. The initial salmonella outbreak at the J.M. Smucker Co. Kentucky plant means products are even being affected as far away as Japan.

CVS Unveils Virtual Care Services For Aetna, Caremark Members

Morning Briefing

Eligible Aetna and CVS Caremark members will be able to use CVS Health Virtual Primary Care to request remote primary care, chronic condition management, and mental health services. The platform will roll out in 2023.

To Tackle Drug Prices, FDA OKs Some Imports Of Drugs From Canada

Morning Briefing

New Food and Drug Administration guidance says that for up to 2 years wholesalers and pharmacists can import prescription drugs from Canada. Separately, a report says that though global cancer drug launches hit a high in 2021, spending on oncology drugs did too.

Navy ‘Separates’ Over 1,000 Sailors Over Covid Shot Refusals

Morning Briefing

Separation, in Navy parlance, is not like being discharged, but means the sailor must leave their active duty position. Meanwhile, at UCLA, an indoor mask rule is back in place after case counts rise. Mix-and-match booster shots, the FDA’s decision on Novavax, and more vaccine news is reported.

Suspected Covid Cases May Soon Not Be Reported By CDC

Morning Briefing

Bloomberg says it has seen a draft of the Centers for Disease Control and Prevention plan on reporting covid cases, and it includes changes to data collection habits that may now be outdated or redundant — including hospitals reporting suspected but untested covid cases.

White House Pushes Easier Access To Paxlovid To Tackle Covid

Morning Briefing

The White House is aiming to improve access to Pfizer’s antiviral drug amid worries that covid will surge during summer travel season. Meanwhile, “Paxlovid mouth” is a growing phenomenon, where patients suffer a “horrible” taste in their mouths after taking the drug.

Senate Panel Floats Telehealth Expansion For Medicare Mental Health Care

Morning Briefing

Included in a telehealth “bill of rights” issued by the Senate Finance Committee Thursday is a measure that would allow Medicare beneficiaries to receive mental health services online without first seeing a provider in person. That requirement was lifted during the pandemic and lawmakers said it was successful.

400 Workers In 5 States Push For Unionization At Planned Parenthood

Morning Briefing

Even as the future of Planned Parenthood seems clouded by the looming Supreme Court decision on Roe v. Wade, around 400 workers are pushing to unionize in Midwest states. The effort is said to be driven by unequal pay matters, staff turnover, and burnout. Other abortion issues are reported.

Doctors, Facing Blowback From Gun Advocates, Galvanize To Fight Violence

Morning Briefing

Doctors insist that gun violence is an urgent public health emergency and began using the hashtag #ThisIsOurLane in 2018 when the National Rifle Association tweeted “someone should tell self-important anti-gun doctors to stay in their lane.” News outlets also look at the impact from school shootings on teachers. Meanwhile, a small, bipartisan group of senators is talking about possible agreement on some initial efforts on gun control.

FDA Chief Suggests Stockpile Of Baby Formula Once Crisis Ends In July

Morning Briefing

Dr. Robert Califf, the FDA commissioner, didn’t recommend specifics for stockpiling the formula during his testimony before a Senate committee. He told senators that he expects the U.S. will have a surplus of formula again in about two months.

First US Health Workers Get Vaccine With Cases Of Monkeypox Rising To 9

Morning Briefing

A small group of Massachusetts General Hospital workers — who had close contact with a patient diagnosed with the monkeypox virus — became the first people in the U.S. to receive the vaccine outside of clinical trials. Meanwhile, the nine people with confirmed cases are being sent treatments.

First Edition: May 27, 2022

Morning Briefing

Today’s early morning highlights from the major news organizations. Note to readers: KHN’s First Edition will not be published Monday, May 30, in honor of Memorial Day. Look for it again in your inbox on Tuesday.

US Tourist Deaths In Bahamas Blamed On Carbon Monoxide

Morning Briefing

The deaths earlier this month had been a puzzle, but reports now say that the three U.S. tourist deaths at a Sandals resort were from carbon monoxide. Sandals has now added CO detectors to guest rooms. Separately, the WHO says global covid cases are beginning to drop again after a surge.

Medicaid Expansion Bill Introduced In North Carolina

Morning Briefing

North Carolina Health News notes that after health care advocates had been pushing for years, “it finally happened.” A separate report in Stateline explains how Medicaid pregnancy care varies very widely across the states, which is significant because 40% of U.S. births are financed by the program.

Legionnaires’ Disease Sickens 19, Kills 1 In Bronx Neighborhood

Morning Briefing

The Health Department is reportedly investigating cooling towers in the borough’s Highbridge section. Also: a child’s death from a polio-like illness is giving clues on enterovirus; a new analysis in San Francisco shows pollution’s impact on Black, Latino, Asian, and low-income residents, and more.

Eli Lilly To Spend $2.1 Billion On New Drug-Making Plants In Indiana

Morning Briefing

Company officials said the new manufacturing sites will make active ingredients and new therapeutic drugs, including those used to treat diabetes, obesity, Alzheimer’s, and cancer. In West Virginia, a tentative agreement has been made on settlements over the opioid crisis, for $161.5 million.